(Q35609459)

9 August 2017

title

Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation (English)

1 reference

9 August 2017

1 reference

1 reference

1

Nitsan Maharshak

1 reference

9 August 2017

Philippe Halfon

2

1 reference

9 August 2017

Varda Deutsch

3

1 reference

9 August 2017

Hava Peretz

4

1 reference

9 August 2017

Shlomo Berliner

5

1 reference

9 August 2017

Sigal Fishman

6

1 reference

9 August 2017

Shira Zelber-Sagi

7

1 reference

9 August 2017

Uri Rozovski

8

1 reference

9 August 2017

Moshe Leshno

9

1 reference

9 August 2017

Ran Oren

10

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

World Journal of Gastroenterology

9 August 2017

published in

1 reference

9 August 2017

volume

17

1 reference

9 August 2017

issue

45

1 reference

9 August 2017

page(s)

5007-5013

1 reference

Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Natural history and predictors of disease severity in chronic hepatitis C.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Laboratory detection of inherited thrombophilia: a historical perspective

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Portal vein thrombosis in a patient with hepatitis C virus-related cirrhosis complicated with antiphospholipid syndrome

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3236579

Portal vein thrombosis in cirrhotics: related with anticardiolipin antibodies?

25 September 2018

1 reference

12 December 2020

A single genetic origin for a common Caucasian risk factor for venous thrombosis

1 reference

12 December 2020

Geographic distribution of the 20210 G to A prothrombin variant

1 reference

12 December 2020

The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population

1 reference

12 December 2020

Fibrophilia: a new disease entity?

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V17.I45.5007

1 reference

9 August 2017

1 reference

9 August 2017

1 reference